@article{9e03d93e9a6f4811930bb2ba63311aab,
title = "Use of clinical history affects accuracy of interpretive performance of screening mammography",
abstract = "Objective: To examine how use of clinical history affects radiologist's interpretation of screening mammography. Study Design and Setting: Using a self-administered survey and actual interpretive performance, we examined associations between use of clinical history and sensitivity, false-positive rate, recall rate, and positive predictive value, after adjusting for relevant covariates using conditional logistic regression. Results: Of the 216 radiologists surveyed (63.4%), most radiologists reported usually or always using clinical history when interpreting screening mammography. Compared with radiologists who rarely use clinical history, radiologists who usually or always use it had a higher false-positive rate with younger women (10.7 vs. 9.7), denser breast tissue (10.1 for heterogeneously dense to 10.9 for extremely dense vs. 8.9 for fatty tissue), or longer screening intervals (> prior 5 years) (12.5 vs. 10.5). Effect of current hormone therapy (HT) use on false-positive rate was weaker among radiologists who use clinical history compared with those who did not (P = 0.01), resulting in fewer false-positive examinations and a nonsignificant lower sensitivity (79.2 vs. 85.2) among HT users. Conclusion: Interpretive performance appears to be influenced by patient age, breast density, screening interval, and HT use. This influence does not always result in improved interpretive performance.",
keywords = "Breast cancer risk, Interpretive acumen, Mammography",
author = "Carney, {Patricia A.} and Cook, {Andrea J.} and Miglioretti, {Diana L.} and Feig, {Stephen A.} and Bowles, {Erin Aiello} and Geller, {Berta M.} and Karla Kerlikowske and Mark Kettler and Tracy Onega and Elmore, {Joann G.}",
note = "Funding Information: This work was supported the National Cancer Institute ( 1R01 CA107623 ; 1K05 CA104699 ; Breast Cancer Surveillance Consortium : U01CA63740 , U01CA86076 , U01CA86082 , U01CA63736 , U01CA70013 , U01CA69976 , U01CA63731 , U01CA70040 ); the Breast Cancer Stamp Fund ; the Agency for Health Care Research and Quality ( R01 CA107623 ); and the American Cancer Society , made possible by a generous donation from the Horizon of Hope Campaign by Longaberger Company ( SIRGS-07-271-01 , SIRGS-07-272-01 , SIRGS-07-273-01 , SIRGS-07-274-01 , SIRGS-07-275-01 , SIRGS-06-281-01 ). The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see, http://breastscreening.cancer.gov/work/acknowledgement.html . The authors had full responsibility in the design of the study, the collection of the data, the analysis and interpretation of the data, the decision to submit the manuscript for publication, and the writing of the manuscript. We thank the participating women, mammography facilities, and radiologists for the data they have provided for this study. A list of the BCSC investigators and procedures for requesting BCSC data for research purposes are provided at http://breastscreening.cancer.gov/ . ",
year = "2012",
month = feb,
doi = "10.1016/j.jclinepi.2011.06.010",
language = "English (US)",
volume = "65",
pages = "219--230",
journal = "Journal of Clinical Epidemiology",
issn = "0895-4356",
publisher = "Elsevier USA",
number = "2",
}